Back to Search
Start Over
Primary angioplasty in Northern Galicia: care changes and results following implementation of the PROGALIAM protocol.
- Source :
-
Revista espanola de cardiologia (English ed.) [Rev Esp Cardiol (Engl Ed)] 2012 Apr; Vol. 65 (4), pp. 341-9. Date of Electronic Publication: 2012 Feb 10. - Publication Year :
- 2012
-
Abstract
- Introduction and Objectives: To analyze changes in healthcare delivery and results for primary angioplasty at Centro Hospitalario Universitario A Coruña following implementation of the PROGALIAM protocol.<br />Methods: Observational registry of 1434 patients referred for primary angioplasty between 2003 and 2007. Results under PROGALIAM (May 2005 - December 2007; n=963) were compared with those from the preceding period (January 2003 - April 2005; n=388).<br />Results: After implementing PROGALIAM, there were increases in the number of primary angioplasty procedures (preceding period, 14.4 cases/month; PROGALIAM, 32.2 cases/month), mean patient age (preceding period, 61.3 (11.9) years; PROGALIAM, 64.2 (11.7) years; P<.001), and the percentage of patients referred from peripheral hospitals and treated after normal working hours. Overall median first medical contact-to-balloon time increased (previous period, 106 min; PROGALIAM, 113 min; P=.02), but decreased significantly among patients referred from noninterventional centers (previous period, 171 min; PROGALIAM, 146 min; P<.001). Percentage of cases with an first medical contact-to-balloon time <120 min remained unchanged among interventional-center patients (preceding period, 69%; PROGALIAM, 71%; P=.56) and increased among patients at noninterventional centers, although it remained low in this subgroup (preceding period, 17%; PROGALIAM, 30%; P=.04). Thirty-day mortality (preceding period, 5.2%; PROGALIAM, 6.2%; P=.85) and 1-year mortality (preceding period, 9.5%; PROGALIAM, 10.2%; P=.96) remained unchanged.<br />Conclusions: Implementation of PROGALIAM allowed us to increase the percentage of patients receiving primary angioplasty without jeopardizing the clinical results of this treatment.<br /> (Copyright © 2011 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.)
- Subjects :
- Abciximab
Aged
Angioplasty, Balloon, Coronary mortality
Antibodies, Monoclonal therapeutic use
Delivery of Health Care
Female
Hospitals, University
Humans
Immunoglobulin Fab Fragments therapeutic use
Length of Stay
Logistic Models
Male
Middle Aged
Myocardial Infarction epidemiology
Patient Transfer
Platelet Aggregation Inhibitors therapeutic use
Prognosis
Spain epidemiology
Treatment Outcome
Angioplasty, Balloon, Coronary statistics & numerical data
Myocardial Infarction therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1885-5857
- Volume :
- 65
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Revista espanola de cardiologia (English ed.)
- Publication Type :
- Academic Journal
- Accession number :
- 22325936
- Full Text :
- https://doi.org/10.1016/j.recesp.2011.11.003